We are live on ! Find out more
BNGOW

Bionano Genomics, Inc. Warrant
BNGOW

Delisted

BNGOW was delisted on the 17th of August, 2023.

Back to rankings

3 hedge funds and large institutions have $330K invested in Bionano Genomics, Inc. Warrant in 2021 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% more capital invested

Capital invested by funds: $170K → $330K (+$160K)

25% less funds holding

Funds holding: 4 → 3 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ICM
Ionic Capital Management
New York
+$392K
2
AWM
Avior Wealth Management
Nebraska
+$2.84K

Top Sellers

Rank Fund Capital Flow
1
MIM
Monashee Investment Management
Massachusetts
-$148K
2
SCM
Silverarc Capital Management
Massachusetts
-$21K
3
UBS Group
UBS Group
Switzerland
-$1K

BNGOW Hedge Fund Activity: Q1 2021 in Review

3 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics, Inc. Warrant (BNGOW) for Q1 2021, worth a combined $330K — up 94% from $170K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of BNGOW and 2 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest buyer was Ionic Capital Management, opening a new position worth an estimated $392K. The largest seller was Monashee Investment Management, exiting entirely with an estimated $148K sold.

  • 3 institutional investors held Bionano Genomics, Inc. Warrant (BNGOW) as of Q1 2021, down from 4 in Q4 2020.
  • Funds reported $330K of Bionano Genomics, Inc. Warrant stock for Q1 2021, up 94% quarter-over-quarter.
  • 2 funds opened new Bionano Genomics, Inc. Warrant positions in Q1 2021 and 3 closed out, a net change of -1 holder.
  • The largest Bionano Genomics, Inc. Warrant buyer in Q1 2021 was Ionic Capital Management, an estimated $392K added.
  • The largest Bionano Genomics, Inc. Warrant seller in Q1 2021 was Monashee Investment Management, an estimated $148K sold.

Based on aggregated 13F filings for Q1 2021.